Aptamer Inhibitors of Osteopontin and Methods of Use Thereof
The present invention polynucleotide aptamers that selectively bind to and inhibit the function of osteopontin, pharmaceutical compositions comprising the same, and methods of use for diagnostics and treatment of diseases and disorders associated with osteopontin.
Attached files:Patents:WO 2,009,102,438
Inventor(s):
KUO PAUL C [US]; MI ZHIYONG [US]; GUO HONGTAO [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents